Cannara Payables Turnover from 2010 to 2024

Stocks . Canada . 
Stock . Cannara Biotech
LOVE Stock  CAD 0.68  0.01  1.49%   
Cannara Biotech Payables Turnover yearly trend continues to be fairly stable with very little volatility. Payables Turnover is likely to outpace its year average in 2024. Payables Turnover is a liquidity ratio that shows how quickly Cannara Biotech pays off its suppliers by dividing total purchases by average accounts payable. View All Fundamentals
 
Payables Turnover  
First Reported
2010-12-31
Previous Quarter
1.94
Current Value
2.04
Quarterly Volatility
0.83048292
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Cannara Biotech financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Cannara Biotech's main balance sheet or income statement drivers, such as Tax Provision of 0.0, Interest Income of 181 K or Interest Expense of 4.7 M, as well as many indicators such as Price To Sales Ratio of 1.7, Dividend Yield of 0.0 or PTB Ratio of 1.22. Cannara financial statements analysis is a perfect complement when working with Cannara Biotech Valuation or Volatility modules.
  
This module can also supplement various Cannara Biotech Technical models . Check out the analysis of Cannara Biotech Correlation against competitors.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Cannara Stock Analysis

When running Cannara Biotech's price analysis, check to measure Cannara Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cannara Biotech is operating at the current time. Most of Cannara Biotech's value examination focuses on studying past and present price action to predict the probability of Cannara Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cannara Biotech's price. Additionally, you may evaluate how the addition of Cannara Biotech to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY